Should VV ECMO be considered as treatment option in COVID‐19 infection after kidney transplant? A word of caution
Clinical Transplantation · 2023
DOI: 10.1111/ctr.15020 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical Transplantation, 2023. Verfasst von Joao Roberto Breda und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Thoracic Transplantation and Mechanical Support, Miami Transplant Institute, University of Miami Miller School of Medicine, Miami, Florid…. Hauptthemen laut MEDLINE: COVID-19, Extracorporeal Membrane Oxygenation, Kidney Transplantation, Respiratory Insufficiency. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Several reports have shown that hospitalized kidney transplant recipients (KTR) had high mortality rates when infected with COVID‐19. Extracorporeal Membrane Oxygenation (ECMO) has been shown to be an option for refractory respiratory failure in COVID‐19 patients with variable rates of recovery. The outcome of ECMO in respiratory failure is highly related to cohort investigated and patient selection. Over a 10‐month period in the height of COVID‐19 pandemic 5 KTR patients were placed on ECMO with none of the patients surviving to discharge. All patients experienced multisystem organ failure (MSOF) and hematologic pathology while on ECMO. We concluded that COVID‐19 in KTR patients presents with a refractory MSOF that is not well supported with ECMO in a traditional approach. Future work is needed to determine how to best support refractory respiratory failure in KTR patients with COVID‐19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Thoracic Transplantation and Mechanical Support, Miami Transplant Institute, University of Miami Miller School of Medicine, Miami, Florida, USA.
- Division of Trauma and Surgical Critical Care, University of Miami Miller School of Medicine, Miami, Florida, USA.
- Division of Kidney Transplant, Miami Transplant Institute, University of Miami Miller School of Medicine, Miami, Florida, USA.
- Medical Student, Ross University School of Medicine, Miramar, Florida, USA.
ORCID-Profile: Joao Roberto Breda, Giselle Guerra
Zitieren
APA
Breda, J. R., Parker, B. M., Guerra, G., Dawson, A., & Loebe, M. (2023). Should VV ECMO be considered as treatment option in COVID‐19 infection after kidney transplant? A word of caution. Clinical Transplantation. https://doi.org/10.1111/ctr.15020
Vancouver
Breda JR, Parker BM, Guerra G, Dawson A, Loebe M. Should VV ECMO be considered as treatment option in COVID‐19 infection after kidney transplant? A word of caution. Clinical Transplantation. 2023. doi:10.1111/ctr.15020
BibTeX
@article{Breda2023,
author = {Breda, Joao Roberto and Parker, Brandon Masi and Guerra, Giselle and Dawson, Akia and Loebe, Matthias},
title = {Should VV ECMO be considered as treatment option in COVID‐19 infection after kidney transplant? A word of caution},
journal = {Clinical Transplantation},
year = {2023},
doi = {10.1111/ctr.15020}
}
EUVIMED